FI843716L - Komposition innehaollande pyridinloesligt extrakt och renat detoxifierat endotoxin och anvaendning av densamma. - Google Patents

Komposition innehaollande pyridinloesligt extrakt och renat detoxifierat endotoxin och anvaendning av densamma.

Info

Publication number
FI843716L
FI843716L FI843716A FI843716A FI843716L FI 843716 L FI843716 L FI 843716L FI 843716 A FI843716 A FI 843716A FI 843716 A FI843716 A FI 843716A FI 843716 L FI843716 L FI 843716L
Authority
FI
Finland
Prior art keywords
och
pyridinloesligt
detoxifierat
renat
densamma
Prior art date
Application number
FI843716A
Other languages
English (en)
Finnish (fi)
Other versions
FI843716A0 (fi
FI843716A7 (fi
Inventor
John Leonard Cantrell
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of FI843716A0 publication Critical patent/FI843716A0/fi
Publication of FI843716A7 publication Critical patent/FI843716A7/fi
Publication of FI843716L publication Critical patent/FI843716L/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/04Mycobacterium, e.g. Mycobacterium tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/05Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/58Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A61K2039/585Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation wherein the target is cancer
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806Antigenic peptides or proteins
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
FI843716A 1983-09-23 1984-09-21 Komposition innehaollande pyridinloesligt extrakt och renat detoxifierat endotoxin och anvaendning av densamma. FI843716L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/535,037 US4663306A (en) 1983-09-23 1983-09-23 Pyridine-soluble extract-refined detoxified endotoxin composition and use

Publications (3)

Publication Number Publication Date
FI843716A0 FI843716A0 (fi) 1984-09-21
FI843716A7 FI843716A7 (fi) 1985-03-24
FI843716L true FI843716L (fi) 1985-03-24

Family

ID=24132594

Family Applications (1)

Application Number Title Priority Date Filing Date
FI843716A FI843716L (fi) 1983-09-23 1984-09-21 Komposition innehaollande pyridinloesligt extrakt och renat detoxifierat endotoxin och anvaendning av densamma.

Country Status (23)

Country Link
US (1) US4663306A (enExample)
JP (1) JPS60120817A (enExample)
KR (1) KR870000843B1 (enExample)
AT (1) AT385659B (enExample)
AU (1) AU566234B2 (enExample)
BE (1) BE900650A (enExample)
CA (1) CA1244765A (enExample)
CH (1) CH664897A5 (enExample)
DE (1) DE3434766C2 (enExample)
DK (1) DK446684A (enExample)
ES (1) ES8608872A1 (enExample)
FI (1) FI843716L (enExample)
FR (1) FR2552326B1 (enExample)
GB (1) GB2149301B (enExample)
HU (1) HU192585B (enExample)
IL (1) IL73034A (enExample)
IN (1) IN157240B (enExample)
IT (1) IT1179444B (enExample)
NL (1) NL8402902A (enExample)
NO (1) NO843776L (enExample)
NZ (1) NZ209635A (enExample)
SE (1) SE8404707L (enExample)
ZA (1) ZA847405B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844894A (en) * 1984-07-12 1989-07-04 Ribi Immunochem Research Inc. Method of inhibiting the onset of septicemia and endotoxemia
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4929604A (en) * 1986-05-28 1990-05-29 Board Of Regents, The University Of Texas System Lipopolysaccharides of reduced toxicity and the production thereof
WO1995005837A1 (en) * 1993-08-27 1995-03-02 Vetrepharm, Inc. Composition and method for stimulation of reproductive performance
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
BE1007823A3 (fr) * 1993-12-10 1995-10-31 Anda Biolog Sa Utilisation d'une composition comprenant au moins un antigene et/ou un ou plusieurs fragments de cet antigene pour l'obtention d'un medicament destine au traitement et/ou a la prevention du cancer.
US5976580A (en) 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
DE19710255A1 (de) * 1997-03-13 1998-09-17 Henkel Ecolab Gmbh & Co Ohg Verwendung einer Lösung zur Desaktivierung von Endotoxinen
HU227921B1 (hu) 1997-08-05 2012-06-28 Bioniche Life Sciences Inc Készítmény és eljárás sejtproliferáció és sejtpusztulás szabályozására
US6019985A (en) * 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
KR100628007B1 (ko) 1998-07-16 2006-09-26 이치로 아즈마 세균의 균체성분을 유효성분으로 하는 암면역요법용 제제
AU785212B2 (en) * 1999-12-13 2006-11-09 Bioniche Life Sciences Inc. Therapeutically useful synthetic oligonucleotides
DK1250152T3 (da) * 1999-12-28 2013-08-26 Bioniche Urology Ip Inc Synergistisk sammensætning indeholdende hyaluronsyre til behandling af cancer
JP5106736B2 (ja) * 2000-07-11 2012-12-26 アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト 臓器線維形成に対するパラポックスウイルスovis株の使用
JP4176021B2 (ja) * 2002-03-05 2008-11-05 セルメディシン株式会社 固体化組織免疫アジュバント
WO2004012751A1 (ja) * 2002-08-02 2004-02-12 Sumitomo Pharmaceuticals Company, Limited 細菌細胞壁骨格成分製剤
FR2848223B1 (fr) * 2002-12-09 2005-02-25 Centre Nat Rech Scient Nouveau procede d'isolement des endotoxines.
AU2003261624A1 (en) * 2003-09-05 2005-03-29 Shenyang Sunbellcom Bio-Pharmaceutical Co., Ltd. A red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion
WO2005102369A1 (ja) * 2004-04-22 2005-11-03 Dainippon Sumitomo Pharma Co., Ltd. 細菌細胞壁骨格成分を含有する製剤
HK1214510A1 (zh) 2013-04-18 2016-07-29 Immune Design Corp. 用於癌症治疗的gla单一疗法
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
PL3158054T3 (pl) 2014-06-17 2025-07-21 Crown Laboratories, Inc. Bakterie zmodyfikowane genetycznie i sposoby modyfikacji genetycznej bakterii
US11504404B2 (en) 2016-02-24 2022-11-22 Crown Laboratories, Inc. Skin probiotic formulation
EP3668957A4 (en) * 2017-08-17 2021-06-02 University of Delaware Furan based compositions and methods of making thereof
JP2023533202A (ja) 2020-06-23 2023-08-02 クラウン ラボラトリーズ,インコーポレイテッド プロバイオティクス皮膚製剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7308450A (enExample) * 1972-06-20 1973-12-27
FR2269962B1 (enExample) * 1974-05-06 1978-02-03 Anvar
JPS58874B2 (ja) * 1979-08-30 1983-01-08 株式会社 目黒研究所 糖蛋白wenac及びその製造法
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1209504A (en) * 1982-06-30 1986-08-12 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism

Also Published As

Publication number Publication date
FR2552326B1 (fr) 1988-05-13
IL73034A (en) 1988-11-15
DK446684D0 (da) 1984-09-19
DE3434766C2 (de) 1987-05-14
KR850002404A (ko) 1985-05-13
NZ209635A (en) 1989-01-27
DK446684A (da) 1985-03-24
SE8404707D0 (sv) 1984-09-20
CH664897A5 (de) 1988-04-15
GB2149301B (en) 1988-06-22
CA1244765A (en) 1988-11-15
AU3340084A (en) 1985-03-28
NO843776L (no) 1985-03-25
SE8404707L (sv) 1985-03-24
FR2552326A1 (fr) 1985-03-29
ZA847405B (en) 1985-05-29
FI843716A0 (fi) 1984-09-21
JPS60120817A (ja) 1985-06-28
ATA302384A (de) 1987-10-15
DE3434766A1 (de) 1986-04-30
HUT35521A (en) 1985-07-29
NL8402902A (nl) 1985-04-16
GB8423993D0 (en) 1984-10-31
GB2149301A (en) 1985-06-12
IT8448894A0 (it) 1984-09-24
IN157240B (enExample) 1986-02-15
KR870000843B1 (ko) 1987-04-25
JPS6254775B2 (enExample) 1987-11-17
ES536167A0 (es) 1986-07-16
BE900650A (fr) 1985-03-21
AU566234B2 (en) 1987-10-15
FI843716A7 (fi) 1985-03-24
HU192585B (en) 1987-06-29
AT385659B (de) 1988-05-10
ES8608872A1 (es) 1986-07-16
US4663306A (en) 1987-05-05
IT1179444B (it) 1987-09-16

Similar Documents

Publication Publication Date Title
FI843716L (fi) Komposition innehaollande pyridinloesligt extrakt och renat detoxifierat endotoxin och anvaendning av densamma.
FI840406A7 (fi) Foerfarande och anordning foer testning av bakterier.
FI832684L (fi) Foerfarande och ungsanordning foer boejning av glasskivor.
FI841982A0 (fi) Anordning och foerfarande foer rengoering av videospelare/bandare.
FI840340L (fi) Kalkmaolfaergdispersion och foerfarande foer framstaellning av denna.
FI840004A0 (fi) Ditiofosfor/amin-salter och dessa innehaollande vattenhaltiga kompositioner
FI840375A7 (fi) Foerfarande foer elektrisk motstaonds- rullsvetsning och svetsmaskin foer genomfoerande av foerfarandet.
FI831524L (fi) Foerfarande och anordning foer aostadkommande av en av intensitetfoerdelning justerbar elektronridao.
FI831802L (fi) Stroemningsregulator och anvaendning av denna.
FI840320L (fi) Foerfarande och anordning foer framstaellning av en multi-cell-skumplastskiva av termoplast.
FI833869A7 (fi) Hydrometallurgiskt foerfarande foer behandling av klorider och fluorider innehaollande raoaemnen av vaerdefulla metaller.
FI832401L (fi) Foerfarande foer framstaellning och belaeggning av skivformiga stycken.
FI832885L (fi) Kapasitiv laesmetod foer kodkort och laesanordning foer foerverkligande av foerfarandet.
FI834876L (fi) Foerfarande och anordning foer framstaellning av dragkedjor av loepande faestkedjor.
FI833228L (fi) Skyddshandske och foerfarande foer tillverkning av densamma.
FI840545A7 (fi) Foerfarande och magasin foer lagring och hantering av lastpallar.
FI840572L (fi) Foerfarande och anordning foer erhaollande och kompensering av en industrirobots banavvikelse.
FI830402L (fi) Foerfarande och anordning foer styrning av funktionen av en borrmaskins matningsmotor.
FI834684A7 (fi) Foerfarande och anordning foer riktning av satellit-mottagningsanten.
FI840627L (fi) Foerfarande foer framstaellning av bakverk och sockerbakverk.
FI834600A7 (fi) Foerfarande och anordning foer aostadkommande av en kontrastbild.
FI834014L (fi) Regleringsfoerfarande och anlaeggning foer genomfoerande av detsamma.
FI841922L (fi) Foerfarande och komposition foer isolering av vitcellselement.
FI831997L (fi) Foerfarande och anordning foer katalytisk oxidering av svaveldioxid.
FI840158L (fi) Saett och anordning foer aostadkommande av automatisk blockering av lastfraonskiljare naermast felstaelle.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: RIBI IMMUNOCHEM RESEARCH, INC.